Literature DB >> 9973292

Mapping of primary congenital lymphedema to the 5q35.3 region.

A L Evans1, G Brice, V Sotirova, P Mortimer, J Beninson, K Burnand, J Rosbotham, A Child, M Sarfarazi.   

Abstract

Primary lymphedema is a chronic tissue swelling, most frequently of the lower limbs, resulting from deficient lymphatic drainage. The variability of the affected phenotype, incomplete penetrance, lack of large families, and possible genetic heterogeneity have hampered the identification of causative genes until now. We carried out a genomewide search, using a four-generation North American family with dominantly inherited primary congenital lymphedema (PCL), otherwise known as "Milroy disease," or "hereditary lymphedema type I" (MIM 153100). Linkage to markers from the 5q35.3 region in this and four additional, British families was established. A minimum of 79 directly scorable haplotypes (37 affected) in five families conspicuously segregated with the most telomeric region of 5q35.3, thus suggesting a major locus for PCL in this vicinity. No recombination was observed with D5S408 (Z = 10.03) and D5S2006 (Z = 8.46) with a combined multipoint score of 16.55. While D5S2073 and WIAF-2213 defined the upper centromeric boundary, no recombinants were obtained for the last telomeric marker of D5S2006. Four unaffected subjects were identified as gene carriers and provided an estimated penetrance ratio of.84 for this condition. A few of the positionally mapped genes in the 5q35 region that may potentially be involved in the etiology of this condition are CANX, FGFR4, HK3, and hnRPH1.

Entities:  

Mesh:

Year:  1999        PMID: 9973292      PMCID: PMC1377764          DOI: 10.1086/302248

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  18 in total

1.  A second-generation linkage map of the human genome.

Authors:  J Weissenbach; G Gyapay; C Dib; A Vignal; J Morissette; P Millasseau; G Vaysseix; M Lathrop
Journal:  Nature       Date:  1992-10-29       Impact factor: 49.962

2.  A NEW SYNDROME COMBINING PTERYGIUM COLLI WITH DEVELOPMENTAL ANOMALIES OF THE EYELIDS AND LYMPHATICS OF THE LOWER EXTREMITIES.

Authors:  H F FALLS; E D KERTESZ
Journal:  Trans Am Ophthalmol Soc       Date:  1964

3.  Hereditary lymphedema and distichiasis.

Authors:  T Kolin; K J Johns; W B Wadlington; M G Butler; M A Sunalp; K W Wright
Journal:  Arch Ophthalmol       Date:  1991-07

4.  Fast and sensitive silver staining of DNA in polyacrylamide gels.

Authors:  B J Bassam; G Caetano-Anollés; P M Gresshoff
Journal:  Anal Biochem       Date:  1991-07       Impact factor: 3.365

Review 5.  Lymphoedema: pathophysiology and classification.

Authors:  N L Browse; G Stewart
Journal:  J Cardiovasc Surg (Torino)       Date:  1985 Mar-Apr       Impact factor: 1.888

6.  Easy calculations of lod scores and genetic risks on small computers.

Authors:  G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

7.  Yellow nail syndrome: with familiar primary hypoplasia of lymphatics, manifest late in life.

Authors:  G C Wells
Journal:  Proc R Soc Med       Date:  1966-05

8.  Additional observations on genetic lymphedema as studied by venography, lymphangiography and radio-isotopic tracers Na22 and RISA.

Authors:  J Beninson; H S Jacobson; W R Eyler; L A DuSault
Journal:  Vasc Surg       Date:  1967-04

9.  The inheritance of primary lymphoedema.

Authors:  R F Dale
Journal:  J Med Genet       Date:  1985-08       Impact factor: 6.318

10.  Congenital hereditary lymphedema in the pig.

Authors:  S C van der Putte
Journal:  Lymphology       Date:  1978-03       Impact factor: 1.286

View more
  17 in total

1.  Cloning, expression and genomic structure of a novel human GNB2L1 gene, which encodes a receptor of activated protein kinase C (RACK).

Authors:  Shu Wang; Jin-Zhong Chen; Zhen Zhang; Shaohua Gu; Chaoneng Ji; Rong Tang; Kang Ying; Yi Xie; Yumin Mao
Journal:  Mol Biol Rep       Date:  2003-03       Impact factor: 2.316

Review 2.  The new era of the lymphatic system: no longer secondary to the blood vascular system.

Authors:  Inho Choi; Sunju Lee; Young-Kwon Hong
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

3.  Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase.

Authors:  A Irrthum; M J Karkkainen; K Devriendt; K Alitalo; M Vikkula
Journal:  Am J Hum Genet       Date:  2000-06-09       Impact factor: 11.025

4.  A model for gene therapy of human hereditary lymphedema.

Authors:  M J Karkkainen; A Saaristo; L Jussila; K A Karila; E C Lawrence; K Pajusola; H Bueler; A Eichmann; R Kauppinen; M I Kettunen; S Yla-Herttuala; D N Finegold; R E Ferrell; K Alitalo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-09       Impact factor: 11.205

5.  Clinical heterogeneity in lymphoedema-distichiasis with FOXC2 truncating mutations.

Authors:  R P Erickson; S L Dagenais; M S Caulder; C A Downs; G Herman; M C Jones; W S Kerstjens-Frederikse; A C Lidral; M McDonald; C C Nelson; M Witte; T W Glover
Journal:  J Med Genet       Date:  2001-11       Impact factor: 6.318

Review 6.  Milroy disease and the VEGFR-3 mutation phenotype.

Authors:  G Brice; A H Child; A Evans; R Bell; S Mansour; K Burnand; M Sarfarazi; S Jeffery; P Mortimer
Journal:  J Med Genet       Date:  2005-02       Impact factor: 6.318

7.  Wide clinical spectrum in a family with hereditary lymphedema type I due to a novel missense mutation in VEGFR3.

Authors:  Ronen Spiegel; Arash Ghalamkarpour; Etty Daniel-Spiegel; Miikka Vikkula; Stavit A Shalev
Journal:  J Hum Genet       Date:  2006-08-19       Impact factor: 3.172

8.  MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema.

Authors:  Johanna Manner; Bernhard Radlwimmer; Peter Hohenberger; Katharina Mössinger; Stefan Küffer; Christian Sauer; Djeda Belharazem; Andreas Zettl; Jean-Michel Coindre; Christian Hallermann; Jörg Thomas Hartmann; Detlef Katenkamp; Kathrin Katenkamp; Patrick Schöffski; Raf Sciot; Agnieszka Wozniak; Peter Lichter; Alexander Marx; Philipp Ströbel
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

Review 9.  Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance?

Authors:  Theodore D Tsirlis; George Papastratis; Kyriaki Masselou; Christos Tsigris; Antonis Papachristodoulou; Alkiviadis Kostakis; Nikolaos I Nikiteas
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

10.  Congenital, low penetrance lymphedema of lower limbs maps to chromosome 6q16.2-q22.1 in an inbred Pakistani family.

Authors:  Sajid Malik; Karl-Heinz Grzeschik
Journal:  Hum Genet       Date:  2008-01-10       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.